OrbiMed Advisors »

Singular Genomics Systems In shares owned by OrbiMed Advisors

Quarter-by-quarter ownership of Singular Genomics Systems In (OMIC) shares owned by OrbiMed Advisors from 13F filings

Historical chart of OrbiMed Advisors investment in Singular Genomics Systems In

Tip: Access up to 7 years of quarterly data

All positions including Singular Genomics Systems In held by OrbiMed Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Singular Genomics Systems In by OrbiMed Advisors

Quarter filed Position value Share count Share price at filing
2024-06-30 $152k 18k 8.45

More positions owned by OrbiMed Advisors

Edgewise Therapeutics (EWTX)
Sinovac Biotech SHS (SVA)
Eli Lilly & Co. (LLY)
Boston Scientific Corporation (BSX)
Intuitive Surgical Com New (ISRG)
Enliven Therapeutics (ELVN)
Biogen Idec (BIIB)
Merck & Co (MRK)
Tenet Healthcare Corp Com New (THC)
Sarepta Therapeutics (SRPT)
Stryker Corporation (SYK)
Silverback Therapeutics (SPRY)
Argenx Se Sponsored Adr (ARGX)
UnitedHealth (UNH)
Q32 Bio (QTTB)

View all positions for OrbiMed Advisors

Top funds holding Singular Genomics Systems In

Tang Capital Management
Deerfield Management Company
Arch Venture Corp
QVIDTVM Management
Vanguard Group
Perceptive Advisors
BlackRock
Geode Capital Management
HighTower Advisors
BlackRock
Tikvah Management
Tower Research Capital
Barclays
Bank of America Corporation
Morgan Stanley

View all funds holding Singular Genomics Systems In